Enhancing Early Detection and Diagnosis in MASH

Panelists discuss how proactive screening and diagnostic strategies can identify MASH earlier in at-risk populations. They describe the implementation of institutional screening protocols, noninvasive imaging, and biochemical scoring systems that allow earlier recognition of hepatic dysfunction.

They explain that early diagnosis not only improves outcomes but also reduces healthcare expenditures by preventing the onset of advanced liver disease. The segment underscores the importance of embedding liver health assessments into standard obesity and diabetes care workflows.

Panelists conclude that integrating screening programs across care settings—through collaboration between clinicians, pharmacists, and wellness coordinators—can build a more preventive, value-based care model for metabolic disease.